{"id":"HHS-OASH-2026-0397-4285","number":"4285","name":"Ken Smith","organization":"","posted":"2026-10-24T04:00Z","received":"2026-10-15T04:00Z","body":"Public Comment on HHS Request for Information: EMF/RF Exposure and Human Health\nDocket No. HHS-OASH-2026-0397\n\nI submit this comment as a concerned consumer urging the Department of Health and Human Services (HHS) to put public health, independent science, and informed consent ahead of commercial interests when evaluating radiofrequency electromagnetic field (RF/EMF) exposure from wireless devices and infrastructure.\n\nWireless technology is everywhere, from phones and Wi-Fi to wearables, smart meters, and cellular networks. Consumers cannot assess safety when exposure information is hard to find and testing may be funded by companies that profit from the products. The public deserves transparent answers.\n\nI do not claim every RF/EMF exposure causes illness or that every alleged harm is established. HHS should identify what is known and unknown, without treating uncertainty as proof of safety or speculation as proof of harm. Policy must follow transparent, reproducible science, free from commercial or advocacy pressure.\n\nI urge HHS to prioritize these actions:\n\n1. INDEPENDENT THIRD-PARTY TESTING. Require qualified labs independent of manufacturers and telecom companies to test devices and infrastructure. Disclose funding, conflicts, methods, calibration, exposure conditions, analyses, and full results. Publish positive and negative findings and make testing reproducible. Industry-funded research must not be the sole basis for declaring a product safe.\n\n2. REAL-WORLD AND CUMULATIVE EXPOSURE. Assess ordinary and high-use scenarios, multiple devices together, and long-term exposure in homes, workplaces, schools, childcare facilities, and neighborhoods. Consider distance, duration, frequency, signal strength, and actual use. Measurements must be independently verifiable and explained plainly.\n\n3. LONG-TERM HEALTH RESEARCH. Fund adequately powered, independently replicated long-term human studies, systematic reviews, and laboratory research on reported concerns involving cancer, cognition, sleep, reproduction, development, cardiovascular outcomes, and other effects. Studies must distinguish correlation from causation, address confounding factors, publish protocols and null findings, and share data when ethical and privacy rules permit.\n\n4. PROTECT VULNERABLE GROUPS. Assess whether added precautions are warranted for children, pregnant people, older adults, people with medical conditions, exposed workers, and users of medical devices. Include schools and childcare facilities.\n\n5. CLEAR CONSUMER DISCLOSURES. Require accessible disclosures of emissions, limits, independent test results, test conditions, limitations, and uncertainty. Explain implications for normal and cumulative exposure. Create a searchable public database of test and adverse-event reports. Marketing must not substitute for evidence.\n\n6. PUBLIC HEALTH MONITORING. Create privacy-protecting systems to report suspected health effects. Investigate credible patterns with validated exposure measurements and clinical assessment. Reports should prompt investigation, not prove causation automatically. Coordinate research and publish findings.\n\n7. ACCOUNTABILITY WHEN HARM IS ESTABLISHED. If reliable evidence shows that a company's product, emissions, concealment, or failure to comply with safety requirements caused or materially contributed to injury, consumers should have meaningful remedies. Congress and regulators should consider requiring responsible companies to cover reasonable medical evaluation, treatment, ongoing care, and appropriate compensation. Companies that knowingly conceal credible safety findings, falsify results, or obstruct required disclosures should face meaningful penalties. Responsibility must be determined fairly, based on evidence, causation, and applicable law.\n\n8. INDEPENDENT OVERSIGHT. Disclose conflicts, publish the basis for conclusions, invite independent peer review, and explain how conflicting evidence is weighed. Review standards as technology and science evolve. Publish who funded studies, what was measured, and why conclusions were reached.\n\nConsumers deserve information about possible risks, and should not bear the full financial burden if evidence establishes preventable harm. Transparency encourages safer design, honest communication, and better science.\n\nI urge HHS to establish rigorous, independent, publicly accountable RF/EMF research and oversight. Where evidence identifies a risk, take proportionate action. Where evidence is uncertain, fund better research and communicate uncertainty honestly. Where evidence does not support an adverse effect, explain that conclusion and the strength and limits of the research. Commercial confidentiality should never hide information essential to public health.\n\nThe public deserves independent testing, accessible data, protections for vulnerable populations, and medical and financial remedies when harm is demonstrated.","attachments":[],"attachment_inventory":true,"withheld":false,"source":"https://www.regulations.gov/comment/HHS-OASH-2026-0397-4285","tags":["cancer-tumors","child-development","sleep-cognition","biology-metabolism","exposure-places","policy-standards","research-evidence"],"source_hash":"ec0af80d5fb13bbf05dc61bb8735f9a2700fe6813cc9fae31e2ef03114005c3c","slug":"cancer-tumors-comment-4285","classification":{"id":"HHS-OASH-2026-0397-4285","body_sha256":"cbc645f98b9b6b428e27ecd5f794fb09e438fa6f6ade7f68ac0ed67c51471f39","status":"ai_reviewed","primary_topic":"research","topics":[{"id":"research","evidence":"\nI urge HHS to prioritize these actions:\n\n1. INDEPENDENT THIRD-PARTY TESTING. Require qualified labs independent of manufacturers and telecom"},{"id":"standards","evidence":"nclude schools and childcare facilities.\n\n5. CLEAR CONSUMER DISCLOSURES. Require accessible disclosures of emissions, limits, independen"},{"id":"children","evidence":"a when ethical and privacy rules permit.\n\n4. PROTECT VULNERABLE GROUPS. Assess whether added precautions are warranted for children, pr"},{"id":"cancer","evidence":"tory research on reported concerns involving cancer, cognition, sleep, reproduction, development, cardiovascular outcomes, and "},{"id":"neurological","evidence":"earch on reported concerns involving cancer, cognition, sleep, reproduction, development, cardiovascular outcomes, and other e"},{"id":"reproductive","evidence":"concerns involving cancer, cognition, sleep, reproduction, development, cardiovascular outcomes, and other effects. Studies must distin"},{"id":"cardiac","evidence":"cognition, sleep, reproduction, development, cardiovascular outcomes, and other effects. Studies must distinguish correlation from ca"},{"id":"occupational","evidence":"lder adults, people with medical conditions, exposed workers, and users of medical devices. Include schools and childcare fac"}],"summary":"The commenter requests independent testing, realistic cumulative-exposure studies, transparent disclosures and oversight, protection of vulnerable groups, and remedies when evidence establishes harm, while emphasizing honest communication of uncertainty.","reviewed_at":"2026-10-24T20:09:12Z","review_method":"Full comment-text review with exact source evidence; attachments not reviewed","review_source_sha256":"37f96760bce557b7b4a954763b65fbf22034985cb003af2c86e22177189b9897","source_url":"https://rfsafe.net/hhs-comments/data/catalog.json","scope":"Original comment body; attachments excluded"},"forum_topics":["research","standards","children","cancer","neurological","reproductive","cardiac","occupational"],"primary_topic":"research","forum_title":"The commenter requests independent testing, realistic cumulative-exposure studies, transparent disclosure…"}